Kun Feng

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Cardiovascular Events

Cancer Stem Cells

Long Noncoding Rna

Top Venues

Signal transduction and targeted therapy

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Pengcheng Zhou, Xuanlong Du, Weilu Jia, Kun Feng, Yewei Zhang
Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer. Signal transduction and targeted therapy 9 (1) (2024)
Hao Peng, Meng Yang, Kun Feng, Qingpeng Lv, Yewei Zhang
Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Hao Peng, Meng Yang, Kun Feng, Qingpeng Lv, Yewei Zhang
Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Pengcheng Zhou, Xuanlong Du, Weilu Jia, Kun Feng, Yewei Zhang
Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer. Signal transduction and targeted therapy 9 (1) (2024)
Hao Peng, Meng Yang, Kun Feng, Qingpeng Lv, Yewei Zhang
Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Hao Peng, Meng Yang, Kun Feng, Qingpeng Lv, Yewei Zhang
Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Pengcheng Zhou, Xuanlong Du, Weilu Jia, Kun Feng, Yewei Zhang
Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer. Signal transduction and targeted therapy 9 (1) (2024)
Xuanlong Du, Pengcheng Zhou, Haidong Zhang, Hao Peng, Xinyu Mao, Shiwei Liu, Wenjing Xu, Kun Feng, Yewei Zhang
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. Cell death & disease 14 (5) (2023)
Xuanlong Du, Pengcheng Zhou, Haidong Zhang, Hao Peng, Xinyu Mao, Shiwei Liu, Wenjing Xu, Kun Feng, Yewei Zhang
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. Cell death & disease 14 (5) (2023)
Xuanlong Du, Pengcheng Zhou, Haidong Zhang, Hao Peng, Xinyu Mao, Shiwei Liu, Wenjing Xu, Kun Feng, Yewei Zhang
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. Cell death & disease 14 (5) (2023)
Xuanlong Du, Pengcheng Zhou, Haidong Zhang, Hao Peng, Xinyu Mao, Shiwei Liu, Wenjing Xu, Kun Feng, Yewei Zhang
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. Cell death & disease 14 (5) (2023)